Podcast

BioCentury This Week

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions…

Download on the App Store

Already have it? Open in the app

Latest episodes

  1. Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick25 Aug 2026
  2. Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA18 Aug 2026
  3. Ep. 381 - FIH urgency in the U.S. Plus: federated learning, biotech IPOs11 Aug 2026
  4. Ep. 380 - AZ-BMS rumors, Replimune, psychedelics4 Aug 2026
  5. Ep. 379 - Argenx M&A, AI giants and biopharma, catalyst scorecard28 Jul 2026
  6. Ep. 378 - U.K. cabinet shuffle, Taiwan biotech and Biogen data21 Jul 2026
  7. Ep. 377 - Trends in life sciences talent with CBRE's Ian Anderson15 Jul 2026
  8. Ep. 376 - M&A momentum: 3Q public markets preview14 Jul 2026
  9. Ep. 375 - Novartis' ADC gambit & regulation as catalyst for U.K. biotech7 Jul 2026
  10. Ep. 374 - Parkinson's deep dive & FDA trial reforms29 Jun 2026